{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-230749","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2026-05-19T20:06:58+00:00","discovered_at":"2026-05-19T20:08:00.356668+00:00","generated_at":"2026-05-19T20:09:26.762673+00:00","sec_items":["5.08","8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Decoy Therapeutics sets July 14, 2026 annual meeting; proposal deadline May 29","bullets":["Annual meeting of stockholders scheduled for July 14, 2026; record date May 22, 2026.","Deadline for Rule 14a-8 stockholder proposals is close of business on May 29, 2026.","Deadline for director nominations and other Bylaw business: May 29, 2026.","Universal proxy rule (Rule 14a-19) notices also due by May 29, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-230749","json":"https://secwatch.observer/filing/0001193125-26-230749.json","markdown":"https://secwatch.observer/filing/0001193125-26-230749.md","text":"https://secwatch.observer/filing/0001193125-26-230749.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000119312526230749/0001193125-26-230749-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000119312526230749/dcoy-20260519.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T20:09:26.762673+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}